Loading stock data…
OFIX
$9.93+0.24 (+2.48%)
Market OpenUpdated 3:44 PM EDT
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Orthofix Medical Inc. in the Healthcare sector is trading at $9.93 with a market capitalization of $393M. Wall Street consensus targets $15.00 (4 analysts), implying a +51.1% move over the next 12 months. The stock is currently near its 52-week low of $9.13, remaining 27.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +51.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 32) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$9.93
Potential Downside
0%
Whystock Fair Value$9.93
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global L...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$392.90M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.79
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-13.79%
Volume
Today's trading volume
262,796
Recent News
How The Orthofix Medical (OFIX) Narrative Is Resetting After CMS Cuts And Guidance Changes
Orthofix Medical is back in focus after a recent reset of its fair value estimate, with the price target moving from US$17.25 to US$15.00, a cut of about 13%. That change lines up with a Street narrative that mixes caution and optimism as analysts weigh the impact of CMS reimbursement updates and the company’s revised long term outlook. Read on to see how different analysts are framing this reset and how you can follow the story as it continues to evolve. Wall Street's queuing for one rocket...
Orthofix Medical and 5 More Stocks See Action From Activist Investors
Activists also report to the SEC on BioLife Solutions, Garrett Motion, Life Time Group Holdings, Infleqtion, and CBL Properties.
How The Orthofix Medical (OFIX) Investment Story Is Resetting After New Guidance And Targets
Orthofix Medical is back in focus as Street price targets reset from prior levels of about US$22 to US$24 down into the mid to high teens, with several firms now clustering around the US$17 to US$20 range. Those trims follow Q4 results, updated margin timelines and new guidance. Together, these have led analysts to temper how quickly they expect earnings to build even as they keep generally constructive views on the business. Read on to see what is driving this shift and how to follow the...
Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported, And Analysts Assigned A US$17.25 Price Target
Investors in Orthofix Medical Inc. ( NASDAQ:OFIX ) had a good week, as its shares rose 2.6% to close at US$12.07...
Orthofix Medical Q1 Earnings Call Highlights
Orthofix Medical (NASDAQ:OFIX) reported first-quarter 2026 results that management said reflect steadier execution, improving stability, and the early benefits of actions taken to reset its Spine commercial channel. Total global net sales for the quarter ended March 31, 2026 were $196.4 million, up